Which version of talazoparib/talazopanib is better, the original version or the generic version?

Talazoparib is a highly selective PARP inhibitor that is mainly used to treat patients with HER2-negative locally advanced or metastatic breast cancer carrying deleterious BRCA mutations. Currently, the original drug of talazoparib has been approved for marketing in mainland China. However, due to the short time to market, the price and medical insurance reimbursement are still unclear. From the perspective of overseas markets, the Hong Kong version of the original drug (1mg, 30 pills) may be priced at more than 50,000 yuan, while the European version of the original drug (0.25mg, 30 pills) is priced at about 10,000 yuan. The price difference is mainly affected by regional pricing strategies and exchange rate fluctuations.

At the same time, generic versions of drugs in Laos, Bangladesh and other countries have also been launched, and the prices are more affordable. Take talazoparib produced by a Lao pharmaceutical factory as an example.1 mg*30 tablets are priced at more than 1,000 yuan, which is about 1/50 of the Hong Kong version of the original drug. These generic drugs usually use the same active pharmaceutical ingredients (API) as the original drugs. Some manufacturers have also passed international certifications such as WHO and EMA, and have certain guarantees in terms of efficacy and safety.

In terms of efficacy, the original drug has been confirmed by large-scale multi-center clinical trials and has relatively comprehensive safety and efficacy data. It is especially effective in controlling disease progression, improving progression-free survival (PFS) and quality of life. Although generic drugs have the same drug structure, they usually lack large-scale long-term follow-up data and are generally recommended as alternatives when the original drug has a heavy price burden or is unavailable.

To sum up, the original drug of talazoparib is more secure in terms of efficacy, stability and regulatory certification, and is the preferred option; while the generic drug version provides a more economical alternative and is suitable for rational use under the guidance of a doctor. When choosing a drug, patients should consider factors such as their condition, financial ability, and whether they have access to regular channels to obtain drugs. It is recommended that medication decisions be made under the guidance of professional doctors to ensure both safety and efficacy.

Reference materials:https://www.talzenna.com/